Variant AAV and compositions, methods and uses for gene transfer to cells, organs and tissues
US9840719B2 · kind B2 · utility
16Cited by
3References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 2014 |
| Grant date | Dec 12, 2017 |
| Priority date | — |
| Expiry date | Feb 1, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/008
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to adeno-associated virus (AAV) serotype AAV-Rh74 and related AAV vectors, and AAV-Rh74 and related AAV vector mediated gene transfer methods and uses. In particular, AAV-Rh74 and related AAV vectors target polynucleotides to cells, tissues or organs for expression (transcription) of genes encoding therapeutic proteins and peptides, and polynucleotides that function as or are transcribed into inhibitory nucleic acid sequences.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.